Literature DB >> 17484701

Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study.

Maurilio Marcacci1, Elizaveta Kon, Vladimir Moukhachev, Andrei Lavroukov, Sergej Kutepov, Rodolfo Quarto, Maddalena Mastrogiacomo, Ranieri Cancedda.   

Abstract

Extensive bone loss is still a major problem in orthopedics. A number of different therapeutic approaches have been developed and proposed, but so far none have proven to be fully satisfactory. We used a new tissue engineering approach to treat four patients with large bone diaphysis defects and poor therapeutic alternatives. To obtain implantable three-dimensional (3D) living constructs, cells isolated from the patients' bone marrow stroma were expanded in culture and seeded onto porous hydroxyapatite (HA) ceramic scaffolds designed to match the bone deficit in terms of size and shape. During the surgical session, an Ilizarov apparatus or a monoaxial external fixator was positioned on the patient's affected limb and the ceramic cylinder seeded with cells was placed in the bone defect. Patients were evaluated at different postsurgery time intervals by conventional radiographs and computed tomography (CT) scans. In one patient, an angiographic evaluation was performed at 6.5 years follow-up. In this study we analyze the long-term outcome of these patients following therapy. No major complications occurred in the early or late postoperative periods, nor were major complaints reported by the patients. No signs of pain, swelling, or infection were observed at the implantation site. Complete fusion between the implant and the host bone occurred 5 to 7 months after surgery. In all patients at the last follow-up (6 to 7 years postsurgery in patients 1 to 3), a good integration of the implants was maintained. No late fractures in the implant zone were observed. The present study shows the long-term durability of bone regeneration achieved by a bone engineering approach. We consider the obtained results very promising and propose the use of culture-expanded osteoprogenitor cells in conjunction with porous bioceramics as a real and significant improvement in the repair of critical-sized long bone defects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17484701     DOI: 10.1089/ten.2006.0271

Source DB:  PubMed          Journal:  Tissue Eng        ISSN: 1076-3279


  175 in total

Review 1.  Mesenchymal stromal cells for cell therapy: besides supporting hematopoiesis.

Authors:  Lei Hao; Huiqin Sun; Jin Wang; Tao Wang; Mingke Wang; Zhongmin Zou
Journal:  Int J Hematol       Date:  2011-12-20       Impact factor: 2.490

2.  Bone regeneration with mesenchymal stem cells.

Authors:  Elizaveta Kon; Giuseppe Filardo; Alice Roffi; Alessandro Di Martino; Mohammad Hamdan; Laura De Pasqual; Maria Letizia Merli; Maurilio Marcacci
Journal:  Clin Cases Miner Bone Metab       Date:  2012-05-29

3.  Angiogenic and osteogenic potential of bone repair cells for craniofacial regeneration.

Authors:  Darnell Kaigler; Giorgio Pagni; Chan-Ho Park; Susan A Tarle; Ronnda L Bartel; William V Giannobile
Journal:  Tissue Eng Part A       Date:  2010-09       Impact factor: 3.845

4.  Runx2 overexpression in bone marrow stromal cells accelerates bone formation in critical-sized femoral defects.

Authors:  Abigail M Wojtowicz; Kellie L Templeman; Dietmar W Hutmacher; Robert E Guldberg; Andrés J García
Journal:  Tissue Eng Part A       Date:  2010-09       Impact factor: 3.845

Review 5.  Musculoskeletal tissue engineering with human umbilical cord mesenchymal stromal cells.

Authors:  Limin Wang; Lindsey Ott; Kiran Seshareddy; Mark L Weiss; Michael S Detamore
Journal:  Regen Med       Date:  2011-01       Impact factor: 3.806

6.  Combinatorial screening of osteoblast response to 3D calcium phosphate/poly(ε-caprolactone) scaffolds using gradients and arrays.

Authors:  Kaushik Chatterjee; Limin Sun; Laurence C Chow; Marian F Young; Carl G Simon
Journal:  Biomaterials       Date:  2010-11-12       Impact factor: 12.479

7.  Stem cell therapy for craniofacial bone regeneration: a randomized, controlled feasibility trial.

Authors:  Darnell Kaigler; Giorgio Pagni; Chan Ho Park; Thomas M Braun; Lindsay A Holman; Erica Yi; Susan A Tarle; Ronnda L Bartel; William V Giannobile
Journal:  Cell Transplant       Date:  2013       Impact factor: 4.064

8.  Stromal cell-derived factor-1β potentiates bone morphogenetic protein-2-stimulated osteoinduction of genetically engineered bone marrow-derived mesenchymal stem cells in vitro.

Authors:  Samuel Herberg; Sadanand Fulzele; Nianlan Yang; Xingming Shi; Matthew Hess; Sudharsan Periyasamy-Thandavan; Mark W Hamrick; Carlos M Isales; William D Hill
Journal:  Tissue Eng Part A       Date:  2012-08-21       Impact factor: 3.845

Review 9.  Biomaterials and stem cells for tissue engineering.

Authors:  Zhanpeng Zhang; Melanie J Gupte; Peter X Ma
Journal:  Expert Opin Biol Ther       Date:  2013-01-17       Impact factor: 4.388

Review 10.  Tissue engineered bone grafts: biological requirements, tissue culture and clinical relevance.

Authors:  Mirjam Fröhlich; Warren L Grayson; Leo Q Wan; Darja Marolt; Matej Drobnic; Gordana Vunjak-Novakovic
Journal:  Curr Stem Cell Res Ther       Date:  2008-12       Impact factor: 3.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.